PER 1.23% 8.0¢ percheron therapeutics limited

I did a check on ISIS news releases. So far there is nothing on...

  1. SRF
    1,046 Posts.
    I did a check on ISIS news releases. So far there is nothing on the Phase 1 trial results on ATL1103 in the US.

    In the previous ATL1102 Phase I trial result and Initiation of Phase 2a, the announcements were joint news release of ANP/ISIS in the US.

    I wonder if ISIS is waiting for the result of Prof Cohen and/or the funding negotiation of Phase 2a trial to release to the market.

    Not forgetting that ATL1103 will also affect the SP of ISIS.

    I won't be surprised if ISIS make a news release before Christmas that will bring ATL1103 in the spotlight around the world.

    And a report in a medical journal should be due anytime soon.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.